Thioridazine-Induced Inhibition of Masturbatory Ejaculation in an Adolescent
Abstract
A case of ejaculatory inhibition during masturbation in an adolescent male treated with thioridazine is reported. Noteworthy is the fact that the patient waited almost a month before revealing the symptom to his physician, unlike the cases involving adults, who complained promptly. Since adolescents are often extremely unwilling to discuss sexual matters, the practitioner prescribing thioridazine to a teenager should be vigilant for the development of this side effect and should not wait for the patient to tell him about it. The role of thioridazine-induced ejaculatory inhibition as a castration threat and therefore as a potential source of anxiety or even of considerable psychic disruption is stressed.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
